INHBA and colon adenocarcinoma: The results showed that INHBA overexpression in bladder urothelial carcinoma (BLCA), colon adenocarcinoma (COAD), Head and Neck cancer (HNSC), and Liver hepatocellular carcinoma (LIHC) et al. (P < 0.05, Fig. 8D).